ANQING CHICO PHARMACEUTICAL CO.,LTD.

Business Type:Trading Company

Main Products:: By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;